{"id":1422,"date":"2025-02-25T10:04:10","date_gmt":"2025-02-25T10:04:10","guid":{"rendered":"https:\/\/amm-journal.org\/?p=1422"},"modified":"2025-02-25T10:04:10","modified_gmt":"2025-02-25T10:04:10","slug":"cholestatic-liver-disease-therapeutic","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/","title":{"rendered":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal. The prevalence of depressive-like behavior is significantly higher in patients with cholestatic liver disease, leading to a notable reduction in the quality of life. This situation underscores the urgent need to investigate the mechanisms underlying the association between cholestasis and clinical depression. This review provides a comprehensive examination of how neuroendocrine disorders resulting from cholestasis influence the onset of depression through both direct and indirect mechanisms. First, how the accumulation of bile acids in the central nervous system (CNS) during cholestasis leads to damage to the blood-brain barrier, neuroinflammation, and neurodegeneration is discussed, highlighting the key roles of bile acid receptors, such as FXR and TGR5, in this process. Additionally, the gut-brain axis has been shown to be involved in the development of brain diseases in a variety of ways. Therefore, the indirect indirect effects of bile acids\u00a0via<\/em>\u00a0the gut-brain axis, which affect the composition of the gut microbiota, the integrity of the gut barrier, and the secretion of gut hormones are summarized, thereby regulating the development of depression. However, whether bile acids can directly enter the CNS and which targets are targetable within the gut-brain axis remain pivotal questions. Addressing these issues will open new avenues for developing more effective therapeutic strategies aimed at alleviating depressive symptoms experienced by patients with cholestasis.<\/p>\n

Read full article at ScienceOpen<\/a>: https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2024-0082<\/a><\/p>\n

Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

# # # # # #<\/strong><\/p>\n

Xin Li, Hong Wang and Yufei Li et al. Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder.\u00a0Acta Materia Medica.\u00a0<\/em>2025. Vol. 4(2):216-232. DOI: 10.15212\/AMM-2024-0082<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. The prevalence of depressive-like behavior is significantly higher in patients with cholestatic liver disease, leading to a notable reduction in the quality of life. This situation underscores the urgent need to investigate the mechanisms underlying the association between cholestasis and clinical depression. This review provides a […]<\/p>\n","protected":false},"author":5,"featured_media":1423,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[440,441,438,446,443,445,442,444,339,439,161],"class_list":["post-1422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","tag-bile-acid-accumulation","tag-blood-brain-barrier","tag-cholestasis-induced-depression","tag-cholestatic-liver-disease-therapeutic","tag-fxr-and-tgr5","tag-gut-microbiota","tag-gut-brain-axis","tag-liver-disease-depression","tag-neurodegeneration","tag-neuroendocrine-mechanisms","tag-neuroinflammation"],"yoast_head":"\nPathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder<\/title>\n<meta name=\"description\" content=\"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder\" \/>\n<meta property=\"og:description\" content=\"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T10:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Suresh PDMR\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Suresh PDMR\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/\"},\"author\":{\"name\":\"Suresh PDMR\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"headline\":\"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder\",\"datePublished\":\"2025-02-25T10:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/\"},\"wordCount\":384,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg\",\"keywords\":[\"Bile acid accumulation\",\"Blood-brain barrier\",\"Cholestasis-induced depression\",\"cholestatic liver disease therapeutic\",\"FXR and TGR5\",\"Gut microbiota\",\"Gut-brain axis\",\"Liver disease depression\",\"neurodegeneration\",\"Neuroendocrine mechanisms\",\"neuroinflammation\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/\",\"name\":\"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg\",\"datePublished\":\"2025-02-25T10:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\"},\"description\":\"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg\",\"contentUrl\":\"https:\\\/\\\/amm-journal.org\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg\",\"width\":1200,\"height\":628,\"caption\":\"cholestatic liver disease therapeutic\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2025\\\/02\\\/25\\\/cholestatic-liver-disease-therapeutic\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/36ab5fda177218467d112d0c1283065e\",\"name\":\"Suresh PDMR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g\",\"caption\":\"Suresh PDMR\"},\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/suresh\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder","description":"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/","og_locale":"en_GB","og_type":"article","og_title":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder","og_description":"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.","og_url":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/","og_site_name":"AMM Journal","article_published_time":"2025-02-25T10:04:10+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg","type":"image\/jpeg"}],"author":"Suresh PDMR","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Suresh PDMR","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/"},"author":{"name":"Suresh PDMR","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"headline":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder","datePublished":"2025-02-25T10:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/"},"wordCount":384,"commentCount":0,"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg","keywords":["Bile acid accumulation","Blood-brain barrier","Cholestasis-induced depression","cholestatic liver disease therapeutic","FXR and TGR5","Gut microbiota","Gut-brain axis","Liver disease depression","neurodegeneration","Neuroendocrine mechanisms","neuroinflammation"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/","url":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/","name":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#primaryimage"},"image":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#primaryimage"},"thumbnailUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg","datePublished":"2025-02-25T10:04:10+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e"},"description":"Uncover neuroendocrine links in cholestasis-induced depression: bile acid accumulation disrupts the BBB and gut-brain axis, revealing new therapeutic targets.","breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#primaryimage","url":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg","contentUrl":"https:\/\/amm-journal.org\/wp-content\/uploads\/2025\/02\/Pathologic-and-therapeutic-insights-into-cholestatic-liver-disease.jpg","width":1200,"height":628,"caption":"cholestatic liver disease therapeutic"},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2025\/02\/25\/cholestatic-liver-disease-therapeutic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/36ab5fda177218467d112d0c1283065e","name":"Suresh PDMR","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78f026916ecafc09393a244fb16a944cf7ed125822beafb24d190ab4192ca56c?s=96&d=mm&r=g","caption":"Suresh PDMR"},"url":"https:\/\/amm-journal.org\/index.php\/author\/suresh\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=1422"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1422\/revisions"}],"predecessor-version":[{"id":1424,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/1422\/revisions\/1424"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media\/1423"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=1422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=1422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=1422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}